Kildare-based Swiftqueue Technologies Limited has been bought by international healthcare software solutions provider Dedalus Group.

Swiftqueue Technologies Limited, a Kernel Capital portfolio company, specialises in hospital appointment and queue management.

Kernel Capital also said today that its portfolio company Oncomark, which is developing a prognostic test for breast cancer, has been purchased by an undisclosed international buyer.

Both Swiftqueue and OncoMark received €650,000 investment from the Bank of Ireland Seed and Early Stage Equity Fund managed by Kernel Capital as early stage companies.

The two trade sales delivered €5m in returns to the fund, which is supported by Bank of Ireland, Enterprise Ireland, The University of Limerick Foundation and the Galway University Foundation.

Kernel said the initial €650,000 investment in the two companies demonstrates the power that pre-seed and seed funding has in being a catalyst for significant Foreign Direct Investment into Ireland.

"Both Swiftqueue and Oncomark have been acquired by global players who are now funding their scaling plans," it added.